Business
Skin Cancer Imaging with MoleMate Featured at American Academy of Dermatology Meeting
Broad Attendance by International and North American Dermatologists MISSISSAUGA, ON, ...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\n\n\n\nBroad Attendance by International and North American Dermatologists\n\n\nMISSISSAUGA, ON, March 23, 2012 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser light therapy\n and light imaging systems, announced that MoleMate and its more robust\n software, SIMSYS, gained the attention of the dermatologists in\n attendance at the American Academy of Dermatology's 70th Annual Meeting, the world's largest, most comprehensive dermatologic\n educational event, which was held March 17-20, 2012, in San Diego,\n California.\n\n\n\"At this meeting, dermatologists had a chance to compare MoleMate to\n recent market entries, and they told us that other devices that would\n help them identify skin cancers early are more costly to acquire and\n use, and do not offer the range of feedback on all moles that is\n possible with MoleMate, and the ability to store and make side-by-side\n comparisons of images to track changes was also an important advantage\n with MoleMate when you are managing patients that have numerous moles\n and a history of suspicious moles,\" said Steve Guillen, President and\n CEO, and that \"the integration of Mole Mapping with MoleMate later in\n the year would be an additional advantage and continue to differentiate\n the MedX products in this new emerging market.\"\n\n\nAbout MoleMate Imaging and Skin Cancer\n\n\nMoleMate recently received approval from Health Canada, and is\n immediately available and in stock for all Canadian physicians, joining\n their colleagues in Europe, the UK, Australia, and the US, who have\n been utilizing this new pain-free, non-invasive imaging system to 'See\n More', approximately 2mm below the surface of suspicious moles, and\n provide additional information and images related to every mole and all\n types of melanomas and non-melanomas.\n\n\nMoleMate uses a patented device and technology that features a hand-held\n scanner designed for office use that utilizes light to view beneath\n suspicious moles or lesions in a pain free, non-invasive manner,\n creating images for physicians to evaluate all types of moles and\n lesions within seconds, providing images that can reveal if a mole is\n benign, or something more serious, often eliminating the need for skin\n biopsies, resulting in less pain, scarring, and expense.  Physicians\n...